Cargando…
A pharmacometrics model to define docetaxel target in early breast cancer
AIMS: We aimed to study the relation between pharmacokinetics (PK) and pharmacodynamics (PD) of docetaxel in early breast cancer and recommend a target exposure. METHODS: A PK/PD study was performed in 27 early breast cancer patients treated with doxorubicin and cyclophosphamide for 4 cycles followe...
Autores principales: | Aldaz, Azucena, Schaiquevich, Paula, Aramendía, José Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087179/ https://www.ncbi.nlm.nih.gov/pubmed/36098504 http://dx.doi.org/10.1111/bcp.15526 |
Ejemplares similares
-
Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel
por: Krishnan, Sreenath M., et al.
Publicado: (2021) -
Pharmacometric estimation methods for aggregate data, including data simulated from other pharmacometric models
por: Välitalo, Pyry Antti Juhana
Publicado: (2021) -
Generation and application of avatars in pharmacometric modelling
por: Chasseloup, Estelle, et al.
Publicado: (2023) -
Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America
por: Ibarra, Manuel, et al.
Publicado: (2019) -
Metaheuristics for pharmacometrics
por: Kim, Seongho, et al.
Publicado: (2021)